Marker Therapeutics (MRKR) Falls 20.6% After Positive Clinical Study
We recently published 10 Stocks Losing Big. Marker Therapeutics, Inc. (NASDAQ:MRKR) is one of the worst performers of Tuesday.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 249,423 | $366,652 | +43% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 32,517 | $47,800 | 0% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.20 | 11,085 | $35,472.00 | 325,370 | 2024-12-23 | Filing | |
| $3.20 | 554,250 | $1,773,600.00 | 1,625,678 | 2024-12-23 | Filing | |
| $17.50 | 14,285 | $249,987.50 | 16,713 | 2021-03-16 | Filing | |
| $2.41 | 10,000 | $24,098.00 | 52,565 | 2021-05-18 | Filing | |
| $1.75 | 5,714,285 | $9,999,998.75 | 10,714,285 | 2021-03-16 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.12 | 160,000 | $19,200.00 | 135,300 | 2011-03-23 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,625,678 | $2,389,747 | 0.15% | |
| 2. | 554,250 | $814,748 | 0.12% | |
| 3. | 426,169 | $626,468 | 0% | |
| 4. | 325,370 | $478,293 | 0.1% | |
| 5. | 139,816 | $205,558 | 0% |